Current Report Filing (8-k)
May 20 2022 - 04:17PM
Edgar (US Regulatory)
false 0000352915 0000352915 2022-05-18
2022-05-18
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 18, 2022
UNIVERSAL HEALTH SERVICES, INC.
(Exact name of registrant as specified in its charter)
Delaware
|
|
1-10765
|
|
23-2077891
|
(State or other jurisdiction of
|
|
(Commission
|
|
(I.R.S. Employer
|
Incorporation or Organization)
|
|
File Number)
|
|
Identification No.)
|
UNIVERSAL CORPORATE CENTER
367 SOUTH GULPH ROAD
KING OF PRUSSIA, Pennsylvania 19406
(Address of principal executive office) (Zip Code)
Registrant’s telephone number, including area code (610)
768-3300
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instructions
A.2. below):
|
|
☐
|
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Class B Common Stock
|
UHS
|
New York Stock Exchange
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§ 230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
Item 5.07 Submission of Matters to a Vote of Security
Holders.
On May 18, 2022, the Company held its 2022 Annual Meeting of
Stockholders. Due to the continuing public health impact of the
COVID-19 pandemic and to support the health and well-being of our
communities, employees, stockholders and other stakeholders, this
year’s Annual Meeting of Stockholders was conducted completely
virtually via a live audio webcast.
At the Annual Meeting, the Company’s stockholders: (i) voted to
elect two Class II members of the Board of Directors for a
three-year term scheduled to expire at the Company’s 2025 Annual
Meeting of Stockholders; (ii) voted to approve the amendment and
restatement of the Company’s 2020 Omnibus Stock and Incentive Plan;
(iii) voted to ratify the selection of PricewaterhouseCoopers, LLP,
as the Company’s independent registered public accounting firm for
the fiscal year ending December 31, 2022, and; (iv) voted against a
stockholder proposal regarding majority vote standard in director
elections if properly presented at the meeting. The final voting
results were as follows:
Proposal No. 1: Election
of Directors:
Warren J. Nimetz – elected
by the Class A and Class C Stockholders:
|
|
Votes cast in favor
|
7,238,788
|
Votes withheld
|
0
|
Broker non-votes
|
0
|
Maria R. Singer – elected
by the Class B and Class D Stockholders:
|
|
Votes cast in favor
|
22,474,461
|
Votes withheld
|
38,738,733
|
Broker non-votes
|
1,690,436
|
Uncast
|
0
|
Proposal No. 2: Amendment
and restatement of the Company’s 2020 Omnibus Stock and Incentive
Plan:
|
|
Votes cast in favor
|
61,182,662
|
Votes cast against
|
3,312,452
|
Votes abstained
|
3,503
|
Broker non-votes
|
175,439
|
Uncast
|
0
|
Proposal No. 3:
Ratification of the selection of PricewaterhouseCoopers, LLP, as
the Company’s independent registered public accounting firm for the
fiscal year ending December 31, 2022:
|
|
Votes cast in favor
|
64,628,550
|
Votes cast against
|
44,555
|
Votes abstained
|
950
|
Broker non-votes
|
0
|
Uncast
|
0
|
Proposal No. 4:
Stockholder proposal regarding majority vote standard in director
elections if properly presented at the meeting:
|
|
Votes cast in favor
|
5,791,615
|
Votes cast against
|
58,703,868
|
Votes abstained
|
3,134
|
Broker non-votes
|
175,439
|
Uncast
|
0
|
As reported above, at the Annual Meeting of Stockholders of the
Company held on May 18, 2022, Maria Singer was elected as a Class
II Director for a term expiring in 2025 by a plurality of the votes
cast by the holders of Class B and Class D Common Stock. The Board
noted that more votes were withheld than were cast in favor of her
election and discussed the implications of that vote. The
Board believes, based on public recommendations of ISS, one of the
largest proxy advisory firms, which are followed by many
institutional stockholders, that the withhold vote was mainly made
as an indication of ISS’s dissatisfaction with certain
governance policies of the Company and not because of any specific
objection to Ms. Singer. Ms. Singer has served on the Board for
less than three years, adds diversity and financial
expertise to the Board and is a valuable member of the
Board. In light of those facts, the Board is pleased that Ms.
Singer will remain as a member of the Board.
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
|
|
|
Universal Health Services, Inc.
|
|
By:
|
|
/s/ Steve Filton
|
Name: Steve Filton
|
Title: Executive Vice President and
Chief
Financial Officer
|
Date: May 20, 2022
Universal Health Services (NYSE:UHS)
Historical Stock Chart
From Feb 2023 to Mar 2023
Universal Health Services (NYSE:UHS)
Historical Stock Chart
From Mar 2022 to Mar 2023